Generics and the specific features of their regulation the importance of adequate regulatory requirements to provide
a comparable therapeutic efficacy and
a comparable
AGOMELATINE (VALDOXAN), ANTIDEPRESSANT WITH A NEW MECHANISM OF ACTIONAGOMELATINE (VALDOXAN), ANTIDEPRESSANT WITH
A NEW MECHANISM OF ACTION
Pharmacotherapy of arterial hypertension in elderly patients: Focus on octogenarians guidelines are presented with
a focus on target levels of blood pressure and drugs of choice